{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:05:16Z","timestamp":1789643116558,"version":"4.0.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jaad.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T16:14:39Z","timestamp":1780676079000},"page":"996-1003","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pregnancy outcomes in patients with biologic-exposed psoriasis: A large cohort study of real-world safety"],"prefix":"10.1016","volume":"95","author":[{"given":"Danielle","family":"Bar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Pavlotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviv","family":"Barzilai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Yinon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jaad.2026.06.006_bib1","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4103\/2229-5178.193906","article-title":"Psoriasis: epidemiology, clinical features, co-morbidities, and clinical scoring","volume":"7","author":"Dogra","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.jaad.2026.06.006_bib2","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.jaad.2026.06.006_bib3","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/1346-8138.15840","article-title":"Psoriasis: comorbidities","volume":"48","author":"Yamazaki","year":"2021","journal-title":"J Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.06.006_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.det.2024.02.007","article-title":"Psoriasis comorbidities and their treatment impact","volume":"42","author":"Taliercio","year":"2024","journal-title":"Dermatol Clin"},{"issue":"1","key":"10.1016\/j.jaad.2026.06.006_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/09546630701364768","article-title":"Psoriasis comorbidities","volume":"19","author":"Gottlieb","year":"2008","journal-title":"J Dermatolog Treat"},{"issue":"7","key":"10.1016\/j.jaad.2026.06.006_bib6","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jamadermatol.2023.1400","article-title":"Global psoriasis Atlas. Fertility trends and adverse pregnancy outcomes in female patients with psoriasis in the UK","volume":"159","author":"Chen","year":"2023","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2026.06.006_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.det.2024.02.001","article-title":"Biologics for psoriasis","volume":"42","author":"Wride","year":"2024","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2026.06.006_bib8","first-page":"39","article-title":"Biologic treatments of psoriasis: an update for the clinician","volume":"15","author":"Brownstone","year":"2021","journal-title":"Biologics"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2026.06.006_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The concept of psoriasis as a systemic inflammation: implications for disease management","volume":"26","author":"Reich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.jaad.2026.06.006_bib10","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1600-0625.2007.00629.x","article-title":"Immunopathogenesis of psoriasis","volume":"16","author":"Sabat","year":"2007","journal-title":"Exp Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2026.06.006_bib11","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.40584","article-title":"Association of maternal inflammation during pregnancy with birth outcomes and infant growth among women with or without HIV in India","volume":"4","author":"Shafiq","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.jaad.2026.06.006_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s12519-025-00909-3","article-title":"Maternal inflammation during the second trimester of pregnancy with adverse birth outcomes: a prospective cohort study","volume":"21","author":"Xiao","year":"2025","journal-title":"World J Pediatr"},{"issue":"2","key":"10.1016\/j.jaad.2026.06.006_bib13","doi-asserted-by":"crossref","DOI":"10.1111\/aji.70055","article-title":"Association of first-trimester combined inflammatory markers (NLR, SII, SIRI, and AISI) with poor obstetric outcomes in pregnancies with ulcerative colitis","volume":"93","author":"Ozkavak","year":"2025","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jaad.2026.06.006_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.molimm.2024.03.009","article-title":"IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches","volume":"171","author":"Elahi","year":"2024","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jaad.2026.06.006_bib15","article-title":"IL-17 regulates adipogenesis, glucose homeostasis, and obesity. J Immunol. 2010;185(11):6947-6959","volume":"186","author":"Z\u00fa\u00f1iga","year":"2011","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2026.06.006_bib16","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jaci.2021.07.005","article-title":"Safety of anti-TNF agents in pregnancy","volume":"148","author":"De Felice","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2026.06.006_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.1.2.6","article-title":"Safety of tumor necrosis factor inhibitors during pregnancy and breastfeeding","volume":"1","author":"Raja","year":"2012","journal-title":"Transl Vis Sci Technol"},{"issue":"5","key":"10.1016\/j.jaad.2026.06.006_bib18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.3390\/ijms19051349","article-title":"The use and safety of TNF inhibitors during pregnancy in women with psoriasis: a review","volume":"19","author":"Johansen","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/j.jaad.2026.06.006_bib19","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ajg.2013.171","article-title":"Safety of anti-TNF agents during pregnancy and breastfeeding in women with inflammatory bowel disease","volume":"108","author":"Gisbert","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2026.06.006_bib20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1741-7015-11-174","article-title":"Safety of TNF-\u03b1 inhibitors during IBD pregnancy: a systematic review","volume":"11","author":"Nielsen","year":"2013","journal-title":"BMC Med"},{"issue":"47","key":"10.1016\/j.jaad.2026.06.006_bib21","doi-asserted-by":"crossref","first-page":"13205","DOI":"10.3748\/wjg.v21.i47.13205","article-title":"Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease","volume":"21","author":"Androulakis","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jaad.2026.06.006_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2025.103827","article-title":"Safety of biologics in patients with autoimmune rheumatic diseases during pregnancy: systematic review and meta-analysis. Autoimmun Rev. 2025;24(8):103827","volume":"24","author":"Li","year":"2025","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2026.06.006_bib23","doi-asserted-by":"crossref","DOI":"10.7573\/dic.2019-11-6","article-title":"Management of psoriasis in pregnancy - a review of the evidence to date","volume":"9","author":"Ferreira","year":"2020","journal-title":"Drugs Context"},{"issue":"11","key":"10.1016\/j.jaad.2026.06.006_bib24","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/ced\/llae209","article-title":"A guide to prescribing systemic treatments for psoriasis during pregnancy, breastfeeding and in those trying to conceive: what does the current evidence suggest?","volume":"49","author":"Hutchison","year":"2024","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.06.006_bib25","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/medicina58060780","article-title":"Oversight and management of women with psoriasis in childbearing Age","volume":"58","author":"Bucur","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"6","key":"10.1016\/j.jaad.2026.06.006_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1586\/1744666X.2015.1037742","article-title":"Psoriasis during pregnancy: characteristics and important management recommendations","volume":"11","author":"Hoffman","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2026.06.006_bib27","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1186\/s12884-023-06033-2","article-title":"Association between disease activity of rheumatoid arthritis and maternal and fetal outcomes in pregnant women: a systematic review and meta-analysis","volume":"23","author":"Lv","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"10.1016\/j.jaad.2026.06.006_bib28","first-page":"155","article-title":"The impact of disease activity and medications on pregnancy and fetal outcomes in women with inflammatory bowel disease: a cohort Study from the IBD-ME Group","volume":"41","author":"Mosli","year":"2025","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226028318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226028318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:00:00Z","timestamp":1789642800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226028318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0190962226028318"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.06.006","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregnancy outcomes in patients with biologic-exposed psoriasis: A large cohort study of real-world safety","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}